Bayer ’ s antibiotic drug-device combo fails in late-stage trial

Bayer (ETR:BAYN) reported last week that its antibiotic drug-device combination product failed in a phase III trial. In the 725-patient Inhale trial, Bayer’s Amikacin Inhale did not out-perform a placebo as a treatment for Gram-negative pneumonia in patients on ventilators. Get the full story at our sister site, Drug Delivery Business News. The post Bayer’s antibiotic drug-device combo fails in late-stage trial appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Bayer nektartherapeutics Source Type: news